| 11 Sept. | 16:00 - 17:30 | |||
| CLOISTER | |||||||
![]() |
|||||||
| HEALTH & NANOMEDICINE |
|||||||
| TT.IV - Technical Multi-Track with Parallel SYMPOSIA | |||||||
| Nano-based drug delivery systems for biomedical applications | |||||||
| Co-organized with Istituto Superiore di Sanità Chairs: Giuseppina BOZZUTO & Maria CONDELLO, Istituto Superiore di Sanità |
|||||||
|
Nanomedicine and nano delivery systems represent key research fields due to increasing employment of materials in the nanoscale range as tools to deliver therapeutic or diagnostic agents to specific organ/tissue sites in a controlled manner. Nanocarriers are being continuously designed to overcome problems associated with conventional chemotherapy, as lack of specificity, low drug stability/bioavailability, systemic toxicity, and onset of drug-resistant phenotypes. Several nanocarriers have allowed improving the therapeutic efficacy of drugs (both synthetic and from natural sources) in preclinical studies and, some of them, also in clinical trials. The workshop “Nano-based drug delivery systems for biomedical applications” will deal with the nanosystem design for drug delivery and preclinical assessment for biomedical applications including cell/tissue targeting, therapy and imaging. |
|||||||
| TT.IV.A.1 |
Giuseppina NOCCA - CV UCSC Synthesis and characterization of drug delivery system for oral lichen planus treatments |
![]() |
|||||
| TT.IV.A.2 |
Cecilia BOMBELLI - CV Institute for Biological Systems (ISB), National Research Council of Italy (CNR) Development of liposomes and chitosan nanoparticles for the delivery of antimicrobial peptides |
![]() |
|||||
| TT.IV.A.3 |
Giovanni BALDI - CV Ce.Ri.Col -Research Center Colorobbia Hybrid magnetic nanoparticles for nanomedicine and immune therapies |
![]() |
|||||
| TT.IV.A.4 |
Beatrice ARASI - CV Istituto Superiore di Sanità MiR126-targeted-nanoparticles combined with PI3K/AKT inhibitor as a new strategy to overcome melanoma resistance |
![]() |
|||||
| Back to Fields & Topics | Back to Plan 11 September | ||




